This inventor holds 1 USPTO granted patent. Top assignee: Genuone Sciences Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Hong-koo Cho in Nail Care
Introduction
Hong-koo Cho is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of nail care through his innovative patent. His work focuses on enhancing the effectiveness of nail treatments, particularly in combating fungal infections.
Latest Patents
One of Hong-koo Cho's key patents is a nail lacquer composition containing ciclopirox. This invention relates to a nail lacquer that includes at least one antifungal agent as a pharmacologically active ingredient. The composition is designed to provide an excellent penetrating effect of the drug in the skin areas where treatment is needed, specifically in fingernails. The formulation includes a polymer material that forms a specific film and a penetration enhancer, making it convenient for management after local application. Additionally, it boasts excellent storage stability of the drug.
Career Highlights
Hong-koo Cho is associated with Genuone Sciences Inc., where he continues to develop innovative solutions in the field of dermatological treatments. His work has garnered attention for its practical applications and effectiveness in treating nail conditions.
Collaborations
Some of his notable coworkers include Jae-seong Lee and Nam-hyang Kim, who contribute to the collaborative efforts in research and development at Genuone Sciences Inc.
Conclusion
Hong-koo Cho's contributions to nail care through his innovative patent demonstrate his commitment to improving treatment options for fungal infections. His work continues to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile